Related Experiment Videos
The relationship between the anti-inflammatory and irritant properties of inflammatory exudate
British Journal of Pharmacology
|May 1, 1970
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identification of a new HLA-DRB5 allele, DRB5*0112, by routine PCR-SSP.
Tissue antigens·2003
Used leucodepletion filters as a source of large quantities of DNA suitable for the study of genetic variations in human populations.
Transfusion medicine (Oxford, England)·2003
Salicylic acid causes a diuresis and natriuresis in normal and common bile-duct-ligated cirrhotic miniature swine.
The Journal of pharmacology and experimental therapeutics·1988
Effects of salicylate vs. aspirin on renal prostaglandins and function in normal and sodium-depleted dogs.
The Journal of pharmacology and experimental therapeutics·1988
Substituted 5H-dibenz[b,g]-1,4-oxazocines and related amino acids with antiinflammatory activity.
Journal of medicinal chemistry·1985
Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights.
British journal of pharmacology·2026
Photodynamic antimicrobial efficacy and mode of action of polypyridyl-based Ru(II) complexes against multidrug-resistant Klebsiella pneumoniae.
British journal of pharmacology·2026
Selective excitatory effects of γ-glutamyl-glycine, a glutathione metabolite, on GluN1 NMDA and mGlu5 receptors impacting synaptic plasticity.
British journal of pharmacology·2026
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.
Journal of human immunity·2026
Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.
International reviews of immunology·2026
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.
Immunity, inflammation and disease·2026